Many different options and approaches are required to treat patients at different stages of infection : Thomas Cueni, Director General, IFPMA https://ift.tt/eA8V8J

The virus is highly complex and a lot remains unknown. Scientists are working at breakneck speed to develop a new vaccine in a tenth of the time. However, the sheer scale of the challenge is daunting. We might need around 12 billion doses of a vaccine once one is available. Today, the five or six biggest vaccine manufacturers produce in total less than half of this volume in a year.

from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Uq2H10